Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Johnson & Johnson | 6.71% | $104.82M | $497.62B | 43.61% | 78 Outperform | |
| AbbVie | 5.24% | $81.77M | $397.98B | 29.33% | 66 Neutral | |
| Exxon Mobil | 5.11% | $79.88M | $504.12B | 6.90% | 74 Outperform | |
| Philip Morris | 5.08% | $79.28M | $233.14B | 18.86% | 63 Neutral | |
| Altria Group | 3.84% | $60.03M | $98.52B | 6.78% | 64 Neutral | |
| Chevron | 3.80% | $59.29M | $304.87B | -2.58% | 71 Outperform | |
| PepsiCo | 3.68% | $57.51M | $204.69B | -6.20% | 78 Outperform | |
| International Business Machines | 3.00% | $46.86M | $292.26B | 33.79% | 79 Outperform | |
| AT&T | 2.97% | $46.40M | $172.91B | 4.02% | 71 Outperform | |
| Merck & Company | 2.84% | $44.41M | $242.30B | -2.21% | 80 Outperform |